BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9115584)

  • 1. Increased expression of G1 cyclins and cyclin-dependent kinases during tumor progression of chemically induced mouse skin neoplasms.
    Zhang SY; Liu SC; Goodrow T; Morris R; Klein-Szanto AJ
    Mol Carcinog; 1997 Mar; 18(3):142-52. PubMed ID: 9115584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D3 expression in melanoma cells is regulated by adhesion-dependent phosphatidylinositol 3-kinase signaling and contributes to G1-S progression.
    Spofford LS; Abel EV; Boisvert-Adamo K; Aplin AE
    J Biol Chem; 2006 Sep; 281(35):25644-51. PubMed ID: 16815849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclins and cyclin dependent kinases during cardiac development.
    Kang MJ; Kim JS; Chae SW; Koh KN; Koh GY
    Mol Cells; 1997 Jun; 7(3):360-6. PubMed ID: 9264023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle transcriptomics of Capsaspora provides insights into the evolution of cyclin-CDK machinery.
    Pérez-Posada A; Dudin O; Ocaña-Pallarès E; Ruiz-Trillo I; Ondracka A
    PLoS Genet; 2020 Mar; 16(3):e1008584. PubMed ID: 32176685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications.
    Abel EL; Angel JM; Kiguchi K; DiGiovanni J
    Nat Protoc; 2009; 4(9):1350-62. PubMed ID: 19713956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDK/CCN and CDKI alterations for cancer prognosis and therapeutic predictivity.
    Bonelli P; Tuccillo FM; Borrelli A; Schiattarella A; Buonaguro FM
    Biomed Res Int; 2014; 2014():361020. PubMed ID: 24605326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymosin beta-10 gene overexpression is a general event in human carcinogenesis.
    Santelli G; Califano D; Chiappetta G; Vento MT; Bartoli PC; Zullo F; Trapasso F; Viglietto G; Fusco A
    Am J Pathol; 1999 Sep; 155(3):799-804. PubMed ID: 10487837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The atypical cell cycle regulator Spy1 suppresses differentiation of the neuroblastoma stem cell population.
    Lubanska D; Porter LA
    Oncoscience; 2014; 1(5):336-48. PubMed ID: 25594028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D3 deficiency inhibits skin tumor development, but does not affect normal keratinocyte proliferation.
    Lee SH; Wang X; Kim SH; Kim Y; Rodriguez-Puebla ML
    Oncol Lett; 2017 Sep; 14(3):2723-2734. PubMed ID: 28927034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effect of cyclin D3 expression and abrogation of cyclin D1 prevent mouse skin tumor development.
    Wang X; Sistrunk C; Miliani de Marval PL; Kim Y; Rodriguez-Puebla ML
    Cell Cycle; 2012 Jan; 11(2):335-42. PubMed ID: 22214766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected reduction of skin tumorigenesis on expression of cyclin-dependent kinase 6 in mouse epidermis.
    Wang X; Sistrunk C; Rodriguez-Puebla ML
    Am J Pathol; 2011 Jan; 178(1):345-54. PubMed ID: 21224071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement for metalloproteinase-dependent ERK and AKT activation in UVB-induced G1-S cell cycle progression of human keratinocytes.
    Han W; He YY
    Photochem Photobiol; 2009; 85(4):997-1003. PubMed ID: 19222789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UVA-induced cell cycle progression is mediated by a disintegrin and metalloprotease/epidermal growth factor receptor/AKT/Cyclin D1 pathways in keratinocytes.
    He YY; Council SE; Feng L; Chignell CF
    Cancer Res; 2008 May; 68(10):3752-8. PubMed ID: 18483258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin D1 is transcriptionally down-regulated by ZO-2 via an E box and the transcription factor c-Myc.
    Huerta M; Muñoz R; Tapia R; Soto-Reyes E; Ramírez L; Recillas-Targa F; González-Mariscal L; López-Bayghen E
    Mol Biol Cell; 2007 Dec; 18(12):4826-36. PubMed ID: 17881732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D2 overexpression in transgenic mice induces thymic and epidermal hyperplasia whereas cyclin D3 expression results only in epidermal hyperplasia.
    Rodriguez-Puebla ML; LaCava M; Miliani De Marval PL; Jorcano JL; Richie ER; Conti CJ
    Am J Pathol; 2000 Sep; 157(3):1039-50. PubMed ID: 10980142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cloning and sequence analysis of the promoter region of mouse cyclin D1 gene: implication in phorbol ester-induced tumour promotion.
    Eto I
    Cell Prolif; 2000 Jun; 33(3):167-87. PubMed ID: 10959625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal and extrachromosomal instability of the cyclin D2 gene is induced by Myc overexpression.
    Mai S; Hanley-Hyde J; Rainey GJ; Kuschak TI; Paul JT; Littlewood TD; Mischak H; Stevens LM; Henderson DW; Mushinski JF
    Neoplasia; 1999 Aug; 1(3):241-52. PubMed ID: 10935479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model.
    Pierce AM; Schneider-Broussard R; Gimenez-Conti IB; Russell JL; Conti CJ; Johnson DG
    Mol Cell Biol; 1999 Sep; 19(9):6408-14. PubMed ID: 10454586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 and human neoplasia.
    Donnellan R; Chetty R
    Mol Pathol; 1998 Feb; 51(1):1-7. PubMed ID: 9624412
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.